CAL
ELV icon

Capital Analysts LLC’s Elevance Health ELV Stock Holding History

Capital Analysts LLC’s Portfolio ELV Stock Details ELV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$218K Sell
743
-29
-4% -$9.53K 0.01% 617
2025
Q4 		$271K Hold
772
– – 0.01% 560
2025
Q3 		$250K Buy
772
+194
+34% +$60.3K 0.01% 552
2025
Q2 		$225K Buy
578
+1
+0.2% +$402 0.01% 529
2025
Q1 		$251K Buy
577
+35
+6% +$14.1K 0.01% 489
2024
Q4 		$200K Sell
542
-21,071
-97% -$8.82M 0.01% 487
2024
Q3 		$11.2M Buy
21,613
+10
+0% +$5.34K 0.46% 48
2024
Q2 		$11.7M Buy
21,603
+654
+3% +$346K 0.52% 42
2024
Q1 		$10.9M Buy
20,949
+83
+0.4% +$41.3K 0.51% 44
2023
Q4 		$9.84M Buy
20,866
+254
+1% +$117K 0.5% 42
2023
Q3 		$8.97M Buy
20,612
+1,367
+7% +$620K 0.5% 38
2023
Q2 		$8.55M Buy
19,245
+851
+5% +$393K 0.48% 38
2023
Q1 		$8.46M Buy
18,394
+108
+0.6% +$51.4K 0.48% 41
2022
Q4 		$9.38M Buy
18,286
+84
+0.5% +$42.6K 0.57% 31
2022
Q3 		$8.27M Buy
18,202
+1,385
+8% +$663K 0.57% 31
2022
Q2 		$8.12M Buy
16,817
+244
+1% +$121K 0.56% 30
2022
Q1 		$8.14M Buy
16,573
+481
+3% +$220K 0.52% 34
2021
Q4 		$7.46M Buy
16,092
+362
+2% +$152K 0.45% 42
2021
Q3 		$5.86M Buy
15,730
+298
+2% +$113K 0.38% 52
2021
Q2 		$5.89M Buy
15,432
+614
+4% +$235K 0.4% 51
2021
Q1 		$5.32M Sell
14,818
-9
-0.1% -$2.89K 0.37% 55
2020
Q4 		$4.76M Buy
14,827
+363
+3% +$111K 0.42% 48
2020
Q3 		$3.88M Buy
14,464
+1
+0% +$269 0.37% 53
2020
Q2 		$3.8M Sell
14,463
-561
-4% -$150K 0.4% 54
2020
Q1 		$3.41M Buy
15,024
+354
+2% +$96.5K 0.42% 56
2019
Q4 		$4.43M Buy
14,670
+94
+0.6% +$25.9K 0.44% 49
2019
Q3 		$3.5M Buy
14,576
+198
+1% +$54.3K 0.37% 64
2019
Q2 		$4.06M Sell
14,378
-584
-4% -$160K 0.44% 53
2019
Q1 		$4.29M Sell
14,962
-378
-2% -$109K 0.5% 40
2018
Q4 		$4.03M Sell
15,340
-187
-1% -$51.4K 0.53% 37
2018
Q3 		$4.25M Buy
15,527
+15,237
+5,254% +$3.96M 0.49% 43
2018
Q2 		$69K Hold
290
– – 0.01% 293
2018
Q1 		$64K Hold
290
– – 0.01% 287
2017
Q4 		$65K Hold
290
– – 0.01% 289
2017
Q3 		$55K Hold
290
– – 0.01% 299
2017
Q2 		$54.6K Buy
+290
New +$52.1K 0.01% 299
2016
Q3 		– Sell
-376
Closed -$49.4K – 410
2016
Q2 		$49.4K Sell
376
-38
-9% -$5.2K 0.01% 266
2016
Q1 		$57.5K Buy
414
+110
+36% +$14.7K 0.01% 256
2015
Q4 		$42.4K Sell
304
-304
-50% -$41.9K 0.01% 290
2015
Q3 		$85.1K Buy
608
+304
+100% +$45.7K 0.02% 241
2015
Q2 		$49.9K Buy
304
+61
+25% +$9.75K 0.01% 280
2015
Q1 		$37.5K Hold
243
– – 0.01% 311
2014
Q4 		$30.5K Sell
243
-574
-70% -$70.9K 0.01% 305
2014
Q3 		$97.7K Buy
817
+164
+25% +$18.8K 0.02% 191
2014
Q2 		$70.3K Sell
653
-100
-13% -$10.3K 0.02% 209
2014
Q1 		$75K Hold
753
– – 0.02% 193
2013
Q4 		$69.6K Sell
753
-236
-24% -$21K 0.02% 188
2013
Q3 		$82.7K Hold
989
– – 0.02% 174
2013
Q2 		$80.9K Buy
+989
New +$74K 0.03% 172

Other funds holding ELV

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Sanders Capital
Sanders Capital West Palm Beach, Florida $83.9B AUM 37.89% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75B AUM 11.27% 1-Year Est. Return

Capital Analysts LLC's ELV Position: Q1 2026 in Review

Capital Analysts LLC reduced its Elevance Health (ELV) stake by 3.8% in Q1 2026, selling an estimated $9.53K and leaving 743 shares worth $218K. The position accounts for 0.01% of the portfolio, ranked #617.

Capital Analysts LLC first reported a position in ELV in Q2 2013 and has held it in 49 quarters since. The position peaked at $11.7M in Q2 2024. 1,464 funds tracked by Wall St. Rank hold ELV as of Q1 2026.

  • Capital Analysts LLC held 743 shares of Elevance Health worth $218K as of Q1 2026.
  • Capital Analysts LLC sold 29 Elevance Health shares in Q1 2026, an estimated $9.53K.
  • Elevance Health made up 0.01% of Capital Analysts LLC's portfolio in Q1 2026, its #617 holding.
  • Capital Analysts LLC first reported a position in Elevance Health in Q2 2013 and has held it in 49 quarters since.
  • Capital Analysts LLC's Elevance Health position peaked at $11.7M in Q2 2024.
  • 1,464 funds tracked by Wall St. Rank held Elevance Health as of Q1 2026.

Based on Capital Analysts LLC's 13F filing for Q1 2026, filed 14 May 2026.